Organ distributions and clearance studies of 99m technetium-labeled corynebacterium parvum in patients with leukemia

Hironobu Toki, Evan M Hersh, Jordan U. Gutterman, Thomas P. Haynie, Howard Glenn, R. Allen White, Adan Rios

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The clearance, metabolism and localization of Corynebacterium parvum (C. parvum) labeled with 99mtechnetium (99mTc) given intravenously was studied in various leukemia patients to develop the method and to evaluate reticuloendothelial systems (RES) function. A computer program was utilized to characterize the clearance. C. parvum 0.05 mg was labeled aseptically with 10 mCi of 99mTc with a reducing agent. It was injected intravenously over 5 s and clearance was characterized over the next 60 min. The low dose of C. parvum did not cause any symptoms. The blood or plasma clearance time (t 1 2) was in the range of 0.65 to 1.96 min, in eight patients. By whole body imaging, the distribution of C. parvum was found mainly in the liver, and to a much lesser extent in the spleen, lungs, and bone marrow. Nonparticulate 99mTc (which was not sedimented by centrifugation of blood samples at 3000 rpm for 30 min) appeared rapidly in the blood after i.v. injection accounting for more than half of the radioactivitu in a few minutes. In vitro incubation of 99mTc labeled C. parvum with saline, whole blood, serum or leukocytes revealed that the release of free 99mTc resulted from the combined action of serum and leukocytes. The rapid clearance will limit the utility of this preparation in characterizing RES function in man and its modification by disease or therapy.

Original languageEnglish (US)
Pages (from-to)141-145
Number of pages5
JournalInternational Journal of Immunopharmacology
Volume3
Issue number2
DOIs
StatePublished - 1981
Externally publishedYes

Fingerprint

Propionibacterium acnes
Technetium
Leukemia
Mononuclear Phagocyte System
Leukocytes
Whole Body Imaging
Reducing Agents
Serum
Centrifugation
Software
Spleen
Bone Marrow
Lung
Injections
Liver

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Organ distributions and clearance studies of 99m technetium-labeled corynebacterium parvum in patients with leukemia. / Toki, Hironobu; Hersh, Evan M; Gutterman, Jordan U.; Haynie, Thomas P.; Glenn, Howard; White, R. Allen; Rios, Adan.

In: International Journal of Immunopharmacology, Vol. 3, No. 2, 1981, p. 141-145.

Research output: Contribution to journalArticle

Toki, Hironobu ; Hersh, Evan M ; Gutterman, Jordan U. ; Haynie, Thomas P. ; Glenn, Howard ; White, R. Allen ; Rios, Adan. / Organ distributions and clearance studies of 99m technetium-labeled corynebacterium parvum in patients with leukemia. In: International Journal of Immunopharmacology. 1981 ; Vol. 3, No. 2. pp. 141-145.
@article{ed018797863245aab3eccd028d7dcc73,
title = "Organ distributions and clearance studies of 99m technetium-labeled corynebacterium parvum in patients with leukemia",
abstract = "The clearance, metabolism and localization of Corynebacterium parvum (C. parvum) labeled with 99mtechnetium (99mTc) given intravenously was studied in various leukemia patients to develop the method and to evaluate reticuloendothelial systems (RES) function. A computer program was utilized to characterize the clearance. C. parvum 0.05 mg was labeled aseptically with 10 mCi of 99mTc with a reducing agent. It was injected intravenously over 5 s and clearance was characterized over the next 60 min. The low dose of C. parvum did not cause any symptoms. The blood or plasma clearance time (t 1 2) was in the range of 0.65 to 1.96 min, in eight patients. By whole body imaging, the distribution of C. parvum was found mainly in the liver, and to a much lesser extent in the spleen, lungs, and bone marrow. Nonparticulate 99mTc (which was not sedimented by centrifugation of blood samples at 3000 rpm for 30 min) appeared rapidly in the blood after i.v. injection accounting for more than half of the radioactivitu in a few minutes. In vitro incubation of 99mTc labeled C. parvum with saline, whole blood, serum or leukocytes revealed that the release of free 99mTc resulted from the combined action of serum and leukocytes. The rapid clearance will limit the utility of this preparation in characterizing RES function in man and its modification by disease or therapy.",
author = "Hironobu Toki and Hersh, {Evan M} and Gutterman, {Jordan U.} and Haynie, {Thomas P.} and Howard Glenn and White, {R. Allen} and Adan Rios",
year = "1981",
doi = "10.1016/0192-0561(81)90004-7",
language = "English (US)",
volume = "3",
pages = "141--145",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Organ distributions and clearance studies of 99m technetium-labeled corynebacterium parvum in patients with leukemia

AU - Toki, Hironobu

AU - Hersh, Evan M

AU - Gutterman, Jordan U.

AU - Haynie, Thomas P.

AU - Glenn, Howard

AU - White, R. Allen

AU - Rios, Adan

PY - 1981

Y1 - 1981

N2 - The clearance, metabolism and localization of Corynebacterium parvum (C. parvum) labeled with 99mtechnetium (99mTc) given intravenously was studied in various leukemia patients to develop the method and to evaluate reticuloendothelial systems (RES) function. A computer program was utilized to characterize the clearance. C. parvum 0.05 mg was labeled aseptically with 10 mCi of 99mTc with a reducing agent. It was injected intravenously over 5 s and clearance was characterized over the next 60 min. The low dose of C. parvum did not cause any symptoms. The blood or plasma clearance time (t 1 2) was in the range of 0.65 to 1.96 min, in eight patients. By whole body imaging, the distribution of C. parvum was found mainly in the liver, and to a much lesser extent in the spleen, lungs, and bone marrow. Nonparticulate 99mTc (which was not sedimented by centrifugation of blood samples at 3000 rpm for 30 min) appeared rapidly in the blood after i.v. injection accounting for more than half of the radioactivitu in a few minutes. In vitro incubation of 99mTc labeled C. parvum with saline, whole blood, serum or leukocytes revealed that the release of free 99mTc resulted from the combined action of serum and leukocytes. The rapid clearance will limit the utility of this preparation in characterizing RES function in man and its modification by disease or therapy.

AB - The clearance, metabolism and localization of Corynebacterium parvum (C. parvum) labeled with 99mtechnetium (99mTc) given intravenously was studied in various leukemia patients to develop the method and to evaluate reticuloendothelial systems (RES) function. A computer program was utilized to characterize the clearance. C. parvum 0.05 mg was labeled aseptically with 10 mCi of 99mTc with a reducing agent. It was injected intravenously over 5 s and clearance was characterized over the next 60 min. The low dose of C. parvum did not cause any symptoms. The blood or plasma clearance time (t 1 2) was in the range of 0.65 to 1.96 min, in eight patients. By whole body imaging, the distribution of C. parvum was found mainly in the liver, and to a much lesser extent in the spleen, lungs, and bone marrow. Nonparticulate 99mTc (which was not sedimented by centrifugation of blood samples at 3000 rpm for 30 min) appeared rapidly in the blood after i.v. injection accounting for more than half of the radioactivitu in a few minutes. In vitro incubation of 99mTc labeled C. parvum with saline, whole blood, serum or leukocytes revealed that the release of free 99mTc resulted from the combined action of serum and leukocytes. The rapid clearance will limit the utility of this preparation in characterizing RES function in man and its modification by disease or therapy.

UR - http://www.scopus.com/inward/record.url?scp=0019505599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019505599&partnerID=8YFLogxK

U2 - 10.1016/0192-0561(81)90004-7

DO - 10.1016/0192-0561(81)90004-7

M3 - Article

VL - 3

SP - 141

EP - 145

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 2

ER -